Jane Street Group, LLC Ascendis Pharma A/S Transaction History
Jane Street Group, LLC
- $88.2 Billion
- Q2 2024
A detailed history of Jane Street Group, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Jane Street Group, LLC holds 16,261 shares of ASND stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,261
Previous 20,394
20.27%
Holding current value
$2.02 Million
Previous $3.08 Million
28.07%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ASND
# of Institutions
227Shares Held
56.7MCall Options Held
138KPut Options Held
249K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.26 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$617 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$534 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$522 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$487 Million0.29% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $6.94B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...